AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM in Zimbabwe
7 products registered with MCAZ — 7 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| VALOSAR-H TABLET; ORAL | 2020/12.3.5/6016 | VARICHEM PHARMACEUTICALS (PVT) LTD | active | 10 Dec 2030 |
| VALOSAR-H TABLET; ORAL | 2020/12.3.5/6015 | VARICHEM PHARMACEUTICALS (PVT) LTD | active | 10 Dec 2030 |
| PRESARTAN H 50 TABLET, COATED; ORAL | 2015/12.3.5/4980 | IPCA LABORATORIES LIMITED | active | 20 Jul 2028 |
| LOSACLO TABLET, COATED; ORAL | 2018/12.3.5/5755 | COSPHARM INVESTMENTS | active | 31 Dec 2027 |
| LOZARCO 100/25 TABLET, COATED; ORAL | 2022/12.3.5/6318 | INNOVATA PHARMACEUTICALS (PTY) LTD | active | 31 Dec 2027 |
| TOZAAR-H TABLET, COATED; ORAL | 2015/12.3.5/5049 | TORRENT PHARMACEUTICALS | active | 31 Dec 2027 |
| HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM TABLET, COATED; ORAL | 2017/12.3.5/5425 | NEW AVAKASH INTERNATIONAL | active | 31 Dec 2027 |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM — MCAZ Registration Details
MCAZ (Zimbabwe) has 7 registered products containing HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM, of which 7 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.